These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10662326)

  • 41. MMR immunisation: what advice should we give to parents?
    Rose V
    Prof Care Mother Child; 1998; 8(3):58-9. PubMed ID: 9814351
    [No Abstract]   [Full Text] [Related]  

  • 42. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract]   [Full Text] [Related]  

  • 43. Surveillance of symptoms following MMR vaccine in children.
    Miller C; Miller E; Rowe K; Bowie C; Judd M; Walker D
    Practitioner; 1989 Jan; 233(1461):69-73. PubMed ID: 2798288
    [No Abstract]   [Full Text] [Related]  

  • 44. MMR vaccine--one year on.
    Walker D
    Practitioner; 1990 May; 234(1489):550-2. PubMed ID: 2392406
    [No Abstract]   [Full Text] [Related]  

  • 45. On the 2002 measles vaccination furore in the UK.
    Spier RE
    Vaccine; 2002 Jul; 20(23-24):2845-7. PubMed ID: 12126892
    [No Abstract]   [Full Text] [Related]  

  • 46. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
    [No Abstract]   [Full Text] [Related]  

  • 47. [MMR-vaccinations and prevention of fatal cases].
    Jacobsen K
    Ugeskr Laeger; 1993 Sep; 155(37):2908. PubMed ID: 8259621
    [No Abstract]   [Full Text] [Related]  

  • 48. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Incubation vaccination ("post-exposure vaccination") with MMR vaccine during a mumps epidemic? The Pediatric Vaccine Counseling Unit].
    Wiersbitzky S; Bruns R; Beyer B
    Kinderarztl Prax; 1992 Oct; 60(7):207-8. PubMed ID: 1359187
    [No Abstract]   [Full Text] [Related]  

  • 50. New evidence reaffirms the safety of the MMR vaccine.
    Glasper EA
    Br J Nurs; 2002 Jun 27-Jul 10; 11(12):794. PubMed ID: 12131827
    [No Abstract]   [Full Text] [Related]  

  • 51. [Infant with febrile convulsions/incidental convulsions in the history: how does one proceed with diphtheria-pertussis-tetanus (DPT) and mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Burtzlaff C
    Kinderarztl Prax; 1993 Nov; 61(9):339-40. PubMed ID: 8114462
    [No Abstract]   [Full Text] [Related]  

  • 52. [Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit].
    Wiersbitzky S; Bruns R; Peters A; Mentel R
    Kinderarztl Prax; 1992 Oct; 60(7):203-5. PubMed ID: 1359186
    [No Abstract]   [Full Text] [Related]  

  • 53. Autism, inflammatory bowel disease, and MMR vaccine.
    O'Brien SJ; Jones IG; Christie P
    Lancet; 1998 Mar; 351(9106):906-7; author reply 908-9. PubMed ID: 9525393
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine.
    Isozaki M; Kuno-Sakai H; Hoshi N; Takesue R; Takakura I; Kimura M; Hikino M; Mitsuda M
    Tokai J Exp Clin Med; 1982 Sep; 7(5):547-50. PubMed ID: 7182947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles, mumps, rubella vaccine and allergy to egg.
    Lang S
    Am Fam Physician; 1998 Sep; 58(4):863-4. PubMed ID: 9767722
    [No Abstract]   [Full Text] [Related]  

  • 56. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The measles-mumps-rubella vaccination program in Finland.
    Lerman SJ
    N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541
    [No Abstract]   [Full Text] [Related]  

  • 58. Allergic reactions to MMR vaccine.
    Kalet A; Berger DK; Bateman WB; Dubitsky J; Covitz K
    Pediatrics; 1992 Jan; 89(1):168-9. PubMed ID: 1728009
    [No Abstract]   [Full Text] [Related]  

  • 59. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Aug; 61(6):227-8. PubMed ID: 8105135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.